ArticleOncotarget2018
Combination of ATO with FLT3 TKIs eliminates FLT3/ITD+ leukemia cells through reduced expression of FLT3.
Kozo Nagai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it
ArticleOncotarget2018
Kozo Nagai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.